# Cancer Prevention and Control

> **NIH NIH P30** · VIRGINIA COMMONWEALTH UNIVERSITY · 2021 · $27,967

## Abstract

CANCER PREVENTION AND CONTROL PROGRAM: PROJECT SUMMARY/ABSTRACT 
The central theme of the Cancer Prevention and Control (CPC) program is to translate its research findings 
into practice and policy to improve the prevention, detection, treatment, and control of cancer. The CPC 
program strives to enhance the quality of life of all individuals affected by cancer, including a large African 
American population served within the MCC catchment area. MCC received distinction as a Minority Based 
NCI Oncology Research Program Community Site to further advance research in this important area of need. 
Additionally, CPC clinical trials and much of the program’s basic science research addresses disparities in this 
population. The CPC program has 36 members representing 12 departments and 4 schools. Currently, the 
CPC program has a total peer-reviewed cancer-related funding base of approximately $6.5 million in direct 
costs, of which nearly $2.3 million is from the NCI and over $3 million is from other NIH institutes. During 2011 
to 2015, the CPC program had a total of 475 publications, of which 22% were intraprogrammatic and 10% 
were interprogrammatic. The scientific goals of the program are highlighted by its themes of (1) reducing 
cancer risk and (2) improving cancer-related care, both of which are tied together by the cross-cutting theme of 
alleviating disparities. CPC continues to achieve significant impact in these areas as evidenced by the 
program’s accomplishments of: translating MCC basic science findings into clinical trials for a novel smoking 
cessation therapy (now in phase IIa clinical trials in collaboration with the University of Pittsburgh Cancer 
Institute); informing the FDA and WHO tobacco policy on modified-risk tobacco products such as e-cigarettes 
with CPC’s first multi-PI P50 grant; decreasing cancer risk through obesity control in high-risk populations– 
adolescents and African Americans; improving cancer screening decision making; enhancing patient and 
caregiver experience with cancer care; identifying Medicaid and other policy effects on access to care; 
identifying barriers to African American enrollment in clinical research trials; and developing methods to 
overcome these barriers. In line with the NCI priority to foster multidisciplinary research, MCC has facilitated 
cross-cutting collaborations by generating an award program dedicated to CPC interprogrammatic pilot 
projects, several of which have recently led to large externally-funded grant projects. Value is added by MCC 
shared resources and CPC-sponsored education and training through monthly seminars, interprogrammatic 
research retreats, competitive CPC pilot grants, and through support of student and trainee fellowships. In 
summary, the CPC program is a vital, dynamic, and growing program within MCC, which addresses the unique 
needs of the MCC catchment area, as well as the nation more generally. The program, with its vibrant research 
agenda, engaged mu...

## Key facts

- **NIH application ID:** 10174773
- **Project number:** 5P30CA016059-40
- **Recipient organization:** VIRGINIA COMMONWEALTH UNIVERSITY
- **Principal Investigator:** DARLENE H BRUNZELL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $27,967
- **Award type:** 5
- **Project period:** 1995-12-01 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10174773

## Citation

> US National Institutes of Health, RePORTER application 10174773, Cancer Prevention and Control (5P30CA016059-40). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10174773. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*